Literature DB >> 10193857

Determinants of postprandial lipemia in obese women.

G Vansant1, A Mertens, E Muls.   

Abstract

OBJECTIVE: To quantify the effects of fasting lipids, age, apolipoprotein (apo) E polymorphism, insulin resistance, body fat and abdominal fat distribution, on postprandial lipemia (PPL) in non-diabetic obese women.
DESIGN: Cross-sectional, prospective.
SUBJECTS: A total of 93 obese women (mean +/- s.d. age 39+/-13y; body mass index (BMI) 38.3+/-4.9 kg/m2) and 16 nonobese women (25+/-8y; BMI 22.7+/-3.2 kg/m2). MEASUREMENTS: Body fat distribution was determined by the ratio of waist-to-hip circumferences (WHR) and by computed tomography (CT) at the L4-L5 level. Apo E genotyping was performed by restriction isotyping. Insulin resistance was calculated from fasting glucose and insulin concentrations. PPL was evaluated using the vitamin A-fat tolerance test (1.0 g fat/kg body weight and 7.0 mg cholesterol/kg body weight+300000 IU vitamin A palmitate). Blood samples were drawn before, and every 1.5 h for 7.5 h plus 24 h after ingestion of the fat meal. Areas under the response curves (AUC) for triglycerides (TG) and retinyl palmitate (RP) were calculated using the geometrical method for two time intervals, that is, 0-7.5 h and 0-24 h.
RESULTS: Incremental AUCs TG, but not AUCs RP, were increased in the obese women. Apo E polymorphism, BMI, WHR and menopausal state did not influence PPL in the obese women. Fasting TG, age, the intra-abdominal to subcutaneous abdominal fat ratio (IA/SC ratio) and insulin resistance were independent determinants of PPL. Together, fasting TG, IA/SC ratio and insulin resistance, explained 38% of the variance in AUC TG 0-7.5 h (P = 0.0001).
CONCLUSION: Alterations in PPL are to be added to the increasing number of components of the plurimetabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193857     DOI: 10.1038/sj.ijo.0800790

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  6 in total

1.  Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.

Authors:  Marguerite R Irvin; Edmond K Kabagambe; Hemant K Tiwari; Laurence D Parnell; Robert J Straka; Michael Tsai; Jose M Ordovas; Donna K Arnett
Journal:  Circ Cardiovasc Genet       Date:  2010-08-21

2.  Effects of orlistat plus diet on postprandial lipemia and brachial artery reactivity in normolipidemic, obese women with normal glucose tolerance: A prospective, randomized, controlled Study.

Authors:  Ibrahim Turker; Nilgun Guvener Demirag; Nedret Tanaci; Nihal Uslu Tutar; Ismail Kirbas
Journal:  Curr Ther Res Clin Exp       Date:  2006-05

3.  Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjects.

Authors:  M A Larsen; R Goll; S Lekahl; O S Moen; J Florholmen
Journal:  Clin Obes       Date:  2015-10-15

Review 4.  Postprandial lipemia: factoring in lipemic response for ranking foods for their healthiness.

Authors:  Cintia Botelho Dias; Paul J Moughan; Lisa G Wood; Harjinder Singh; Manohar L Garg
Journal:  Lipids Health Dis       Date:  2017-09-18       Impact factor: 3.876

5.  Quantile-dependent expressivity of postprandial lipemia.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

6.  Predicting postprandial lipemia in healthy adults and in at-risk individuals with components of the cardiometabolic syndrome.

Authors:  R Scott Rector; Melissa A Linden; John Q Zhang; Shana O Warner; Thomas S Altena; Bryan K Smith; George G Ziogas; Ying Liu; Tom R Thomas
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.